CAR is a significant inflammatory biomarker for assessing prognosis in patients with certain cancer [15, 29–31], and has been shown to have a better predictive value than hs-CRP and albumin alone in terms of ischemic events [21, 32]. The gene discussed is ALB; the disease is cancer.